ArticleBMJ open2025

Canakinumab for the treatment of postprandial hypoglycaemia: study protocol for a randomised, placebo-controlled, parallel-group, double-blind, multicentric, superiority trial-the CanpHy study.

Matthias Hepprich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.